Keisaku Wakabayashi, Fuminori Sakurai, Ryosuke Ono, Toshiyoshi Fujiwara, Hiroyuki Mizuguchi. Development of a Novel Oncolytic Adenovirus Expressing a Short-hairpin RNA Against Cullin 4A. Anticancer research. 2020. 40. 1. 161-168
Masahisa Hemmi, Masashi Tachibana, Natsuki Fujimoto, Masaki Shoji, Fuminori Sakurai, Kouji Kobiyama, Ken J. Ishii, Shizuo Akira, Hiroyuki Mizuguchi. Type I IFN signaling induces Th17 cells capable of promoting gut-mucosal CTLs following intramuscular vaccination of an adenovirus vector. CYTOKINE. 2017. 100. 150-150
Kahori Shimizu, Sakurai Fuminori, Shunsuke Iizuka, Masashi Tachibana, Toru Nishinaka, Tomoyuki Terada, Hiroyuki Mizuguchi. Adenovirus Vector-Induced Hepatotoxicity During the Early Phase of Adenoviral Treatment Is Attributed to Inflammatory Cytokine-Induced Leaky Expression of Adenovirus Genes. MOLECULAR THERAPY. 2017. 25. 5. 264-265
F. Sakurai, T. Kaminade, M. Tachibana, H. Mizuguchi. Reovirus-mediated efficient killing of cancer-associated fibroblasts. HUMAN GENE THERAPY. 2016. 27. 11. A86-A86
日本免疫毒性学会
, 日本ウイルス学会
, 日本癌学会
, 日本DDS学会
, 日本薬学会
, 日本遺伝子細胞治療学会
, アメリカ遺伝子治療学会
, The Japanese Cancer Association
, Japan Society of Drug Delivery System
, The Japan Society of Gene Therapy
, American Society of Gene Therapy
, 日本薬剤学会